Merck said on Thursday its experimental antibody ... The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the company ...

Merck & Co., Inc. (NYSE:MRK) is a U.S.-based pharmaceutical company that focuses on producing vaccines and providing hospital care services. Its top-selling cancer drug, Keytruda, is a standout ...

Merck (NYSE:MRK) announced Wednesday that its 21-valent pneumococcal vaccine, Capvaxive, approved in the U.S. to prevent pneumonia, generated positive immune responses in a Phase 3 trial for ...

Chile has launched a vaccine described as the first of its kind that sterilizes dogs for a year and is expected to be sold in ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

Merck & Co has joined with the non-profit scientific research organisation, the International AIDS Vaccine Initiative (IAVI), to develop a potential vaccine against the SARS-CoV-2 coronavirus that ...

The event will cover strategies for attendees to protect themselves and their pets in the event they are approached by a loose dog. Organizers ... Pet microchips and vaccines will be available ...